CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 47,257 shares at an average $63.73 ($3,011,592)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $64.91 ($16,228)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Planned sale SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $63.44 ($1,268,800)
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 20,000 shares at $58.90 ($1,178,000)
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 30,000 shares at an average $60.59 ($1,817,663)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $63.80 ($15,950)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 11,087 shares (to pay taxes)
- 4 Open-market sale SVP, GENERICS sold 2,985 shares at $67.00 ($199,995)
- 4 Open-market sale SVP & CFO sold 5,000 shares at $63.58 ($317,900)
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $64.41 ($1,288,200)
Page 14 of 90 · 1,784 filings